Skip to main content

Cancer Immunology, Immunotherapy

Ausgabe 9/2021

Inhalt (26 Artikel)

Metabolic profiles of regulatory T cells in the tumour microenvironment

  • Review

Disha Rao, Fabienne Verburg, Kathrin Renner, Daniel S. Peeper, Ruben Lacroix, Christian U. Blank

Myeloid cell heterogeneity in lung cancer: implication for immunotherapy

  • Review

Sabina Sangaletti, Roberto Ferrara, Claudio Tripodo, Marina Chiara Garassino, Mario Paolo Colombo

Interleukin-7-loaded oncolytic adenovirus improves CAR-T cell therapy for glioblastoma

  • Original Article

Jianhan Huang, Meijun Zheng, Zongliang Zhang, Xin Tang, Yaxing Chen, Aijun Peng, Xingchen Peng, Aiping Tong, Liangxue Zhou

IL-36γ-armed oncolytic virus exerts superior efficacy through induction of potent adaptive antitumor immunity

  • Open Access
  • Original Article

Min Yang, Esther Giehl, Chao Feng, Mathilde Feist, Hongqi Chen, Enyong Dai, Zuqiang Liu, Congrong Ma, Roshni Ravindranathan, David L. Bartlett, Binfeng Lu, Zong Sheng Guo

Platelet-expressed immune checkpoint regulator GITRL in breast cancer

  • Open Access
  • Original Article

Yanjun Zhou, Jonas S. Heitmann, Kim L. Clar, Korbinian N. Kropp, Martina Hinterleitner, Tobias Engler, André Koch, Andreas D. Hartkopf, Lars Zender, Helmut R. Salih, Stefanie Maurer, Clemens Hinterleitner

Normalization of electroretinogram and symptom resolution of melanoma-associated retinopathy with negative autoantibodies after treatment with programmed death-1 (PD-1) inhibitors for metastatic melanoma

  • Open Access
  • Original Article

Karam Khaddour, Sangeeta Khanna, Michael Ansstas, Ishaan Jakhar, Sonika Dahiya, Laurin Council, George Ansstas

Enhanced anti-tumor efficacy of IL-7/CCL19-producing human CAR-T cells in orthotopic and patient-derived xenograft tumor models

  • Original Article

Shunsuke Goto, Yukimi Sakoda, Keishi Adachi, Yoshitaka Sekido, Seiji Yano, Masatoshi Eto, Koji Tamada

Anlotinib combined with PD-1 blockade for the treatment of lung cancer: a real-world retrospective study in China

  • Original Article

Xiangyu Zhang, Liang Zeng, Yizhi Li, Qinqin Xu, Haiyan Yang, Analyn Lizaso, Xinru Mao, Ren’an Jin, Yu Zeng, Qinglin Li, Jianbo Wang, Yang Li, Yongchang Zhang, Nong Yang

The liposome of trehalose dimycolate extracted from M. bovis BCG induces antitumor immunity via the activation of dendritic cells and CD8+ T cells

  • Original Article

Masanobu Shiga, Jun Miyazaki, Kozaburo Tanuma, Yoshiyuki Nagumo, Takayuki Yoshino, Shuya Kandori, Hiromitsu Negoro, Takahiro Kojima, Ryota Tanaka, Naoko Okiyama, Yasuhiro Fujisawa, Miyuki Watanabe, Sho Yamasaki, Hideyasu Kiyohara, Makoto Watanabe, Taka-aki Sato, Hideaki Tahara, Hiroyuki Nishiyama, Ikuya Yano

The cytokine milieu compromises functional capacity of tumor-infiltrating plasmacytoid dendritic cells in HPV-negative but not in HPV-positive HNSCC

  • Original Article

Vladimír Koucký, Kamila Hladíková, Eliška Táborská, Jan Bouček, Marek Grega, Radek Špíšek, Anna Fialová

Immune-related adverse events: promising predictors for efficacy of immune checkpoint inhibitors

  • Original Article

Li Zhong, Qing Wu, Fuchun Chen, Junjin Liu, Xianhe Xie

PD-L1 amplification is associated with an immune cell rich phenotype in squamous cell cancer of the lung

  • Open Access
  • Original Article

Torsten Goldmann, Sebastian Marwitz, Dörte Nitschkowski, Rosemarie Krupar, Max Backman, Hedvig Elfving, Viktoria Thurfjell, Amanda Lindberg, Hans Brunnström, Linnea La Fleur, Artur Mezheyeuski, Johanna Sofia Margareta Mattsson, Johan Botling, Patrick Micke, Carina Strell

Novel roles of VAT1 expression in the immunosuppressive action of diffuse gliomas

  • Original Article

Pei Yang, Kuanyu Wang, Chuanbao Zhang, Zhiliang Wang, Qi Liu, Jiangfei Wang, Tao Jiang, Xia Shan

Regulatory T cells promote glioma cell stemness through TGF-β–NF-κB–IL6–STAT3 signaling

  • Open Access
  • Original Article

Shasha Liu, Chaoqi Zhang, Boqiao Wang, Huanyu Zhang, Guohui Qin, Congcong Li, Ling Cao, Qun Gao, Yu Ping, Kai Zhang, Jingyao Lian, Qitai Zhao, Dan Wang, Zhen Zhang, Xuan Zhao, Li Yang, Lan Huang, Bo Yang, Yi Zhang

Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial

  • Open Access
  • Original Article

Kjetil Boye, Alessandra Longhi, Tormod Guren, Susanne Lorenz, Stine Næss, Michela Pierini, Ingeborg Taksdal, Ingvild Lobmaier, Marilena Cesari, Anna Paioli, Ayca M. Løndalen, Elisabetta Setola, Ivar Hompland, Leonardo A. Meza-Zepeda, Kirsten Sundby Hall, Emanuela Palmerini

Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer

  • Original Article

Reem Saleh, Varun Sasidharan Nair, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord, Ranad Shaheen

Correction to: Transcriptome of CD8+ tumor-infiltrating T cells: a link between diabetes and colorectal cancer

  • Correction

Reem Saleh, Varun Sasidharan Nair, Khaled Murshed, Mohamed Abu Nada, Eyad Elkord, Ranad Shaheen

Prognostic role of the systemic immune–inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration

  • Open Access
  • Original Article

Keiichiro Mori, Irene Resch, Noriyoshi Miura, Ekaterina Laukhtina, Victor M. Schuettfort, Benjamin Pradere, Satoshi Katayama, David D’Andrea, Mehdi Kardoust Parizi, Mohammad Abufaraj, Wataru Fukuokaya, Claudia Collà Ruvolo, Stefano Luzzago, Sophie Knipper, Carlotta Palumbo, Pierre I. Karakiewicz, Alberto Briganti, Dmitry V. Enikeev, Morgan Rouprêt, Vitaly Margulis, Shin Egawa, Shahrokh F. Shariat

Heterogeneity of PD-L1 expression between invasive and lepidic components of lung adenocarcinomas

  • Original Article

Antonious Hazim, Neil Majithia, Stephen J. Murphy, Dennis Wigle, Marie-Christine Aubry, Aaron S. Mansfield

Development and validation of a PD-L1/PD-1/CD8 axis-based classifier to predict cancer survival of upper tract urothelial carcinoma after radical nephroureterectomy

  • Original Article

Junyu Chen, Wenlong Zhong, Meng Yang, Weibin Hou, Xiaofei Wang, Kun Xia, Hao Yu, Meihua Yang, Bingkun Zhou, Bo Wang, Jian Huang, Tianxin Lin

Identification of immune checkpoint and cytokine signatures associated with the response to immune checkpoint blockade in gastrointestinal cancers

  • Original Article

Chuanhua Zhao, Lihong Wu, Dandan Liang, Huan Chen, Shoujian Ji, Guanxiong Zhang, Keyan Yang, Ying Hu, Beibei Mao, Tianshu Liu, Yiyi Yu, Henghui Zhang, Jianming Xu

Anti-tumor effects of RTX-240: an engineered red blood cell expressing 4-1BB ligand and interleukin-15

  • Open Access
  • Original Article

Shannon L. McArdel, Anne-Sophie Dugast, Maegan E. Hoover, Arjun Bollampalli, Enping Hong, Zafira Castano, Shannon Curtis Leonard, Sneha Pawar, Jennifer Mellen, Kelvin Muriuki, Douglas C. McLaughlin, Nicholas Bayhi, Christopher L. Carpenter, Laurence A. Turka, Thomas J. Wickham, Sivan Elloul

Correlation between melatonin concentration and cytokines in cervical mucus in positive samples for the presence of human papillomavirus

  • Research Report

Aron Carlos de Melo Cotrim, Eduardo Luzia França, Jordana Santos Martins, Katleyn Polizeli Galvão Silva, Mahmi Fujimori, Yehya Chakib Ghalfi, Izabela Trindade Machado, Adenilda Cristina Honorio-França, Inês Aparecida Tozetti

Neu im Fachgebiet Onkologie

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

NSCLC: Hirnmetastasen durch elektrische Felder eindämmen

Zur Behandlung von Hirnmetasen bei nicht-kleinzelligem Lungenkrebs (NSCLC) stehen verschiedene Optionen zur Verfügung. TTFields – eine lokoregionäre, nicht-invasive physikalische Therapie – könnte sich hier einreihen.

Kontrollkoloskopie nach Polypektomie: Wann ist eine zweite Untersuchung nötig?

Wann benötigen polypektomierte Patienten und Patientinnen mehr als eine endoskopische Nachsorgeuntersuchung? Eine Kohortenstudie aus Großbritannien legt eine konkrete Strategie nahe.

Wenn die Krebstherapie die Identität verändert

Tumortherapien können die Fingerbeere so verändern, dass eine Fingerabdruck-abhängige Identitätskontrolle fehlschlägt. Dafür sprechen zumindest Daten aus der Literatur, die Forschende nun erstmals für ein Review zusammengetragen haben. Vieles ist im Moment aber noch unklar.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.